Figure 7.
Figure 7. Targeting SOCS-1 deficiency to hepatocytes exacerbates the hepatocyte damage in Socs1lox/- LysM-cre mice. (A) Survival curves of Socs1lox/- Alb-cre (▴; n = 6), Socs1lox/- Alb-cre/LysM-cre (▪; n = 14), and Socs1lox/- Alb-cre/Lck-cre (•; n = 6) mice. (B) Liver pathology in Socs1lox/- Alb-cre/LysM-cre mice compared with (C) Socs1lox/- Alb-cre mice. Note the swelling of hepatocytes that is not seen in Socs1lox/- LysM-cre mice (Figure 2A). Collapsed hepatocytes (*) and vacuole formation within hepatocytes (arrow) are also readily identifiable.

Targeting SOCS-1 deficiency to hepatocytes exacerbates the hepatocyte damage in Socs1lox/-LysM-cre mice. (A) Survival curves of Socs1lox/-Alb-cre (▴; n = 6), Socs1lox/-Alb-cre/LysM-cre (▪; n = 14), and Socs1lox/-Alb-cre/Lck-cre (•; n = 6) mice. (B) Liver pathology in Socs1lox/-Alb-cre/LysM-cre mice compared with (C) Socs1lox/-Alb-cre mice. Note the swelling of hepatocytes that is not seen in Socs1lox/-LysM-cre mice (Figure 2A). Collapsed hepatocytes (*) and vacuole formation within hepatocytes (arrow) are also readily identifiable.

Close Modal

or Create an Account

Close Modal
Close Modal